Press release

December 5, 2017

Prime Therapeutics statement on CVS-Aetna merger announcement 


ST. PAUL, Minn. – Prime Therapeutics LLC (Prime), a leading pharmacy benefit manager (PBM) serving more than 20 million members nationally, issued the following statement from its President and CEO Jim DuCharme

“The recent announcement of CVS's intention to buy Aetna is another example of the constant change occurring in health care and a resounding validation of the improved coordination across the continuum of care that we achieved through our Walgreens Prime Strategic Alliance earlier this year – which integrated the health insurer, the PBM and the retail pharmacy. Through our collaboration with Walgreens, one of America's largest pharmacy chains, we have already achieved significant savings and we are working on exciting new ways to leverage the in-store visit as a unique and important portal for improving patient health and satisfaction. It is but one example of how Prime’s direct connection with other parts of the health care industry puts us in a strong position for delivering exceptional value to our current clients and achieving future growth. 

Prime has long offered its clients a unique, fully transparent, lowest net cost business model as many of our clients are also our owners. Also, being owned by 18 Blue Cross and Blue Shield health plans, has given Prime the ability to integrate medical and pharmacy benefits. For nearly twenty years, we’ve understood the value of aligning different components of the health care system, to give us a much more complete picture and ultimately best manage total health care costs. And our alignment and integration is succeeding as evidenced by the fact that Prime is delivering the lowest drug trend of any PBM.”


About Prime Therapeutics

Prime Therapeutics LLC (Prime) helps people get the medicine they need to feel better and live well. Prime manages pharmacy benefits for health plans, employers, and government programs including Medicare and Medicaid. The company processes claims and offers clinical services for people with complex medical conditions. Prime serves more than 20 million people. It is collectively owned by 18 Blue Cross and Blue Shield Plans, subsidiaries or affiliates of those plans.

Follow @Prime_PBM on Twitter.

Sign-up for regular news announcements from Prime Therapeutics.

Contact

Karen Lyons, APR
Prime Therapeutics
Director, Communications
612.777.5742
KLyons@primetherapeutics.com